2026 adjusted financial highlights*
Revenue
£423.2m
(3.0%) organic constant currency (OCC)2
Operating profit (OCC)
£73.7m
(1.6%)
Operating profit margin
17.4%
(50) basis points
Operating profit margin (OCC)
18.2%
+30 basis points
Dividend per share (proposed)
23.6p
Basic earnings per share
100.7p
*Adjusted items exclude the amortisation and impairment of acquired intangible assets, acquisition items, business reorganisation costs, other significant non-recurring items, and the mark-to-market movement of financial derivatives. References to year-on-year movements and margin percentages are shown at organic constant currency (OCC), prepared using prior year results translated at the current reporting year’s average exchange rates excluding disposals, and acquisitions are not included until the prior year includes a full year of performance. Comparators have been restated to reclassify NanoScience business as a discontinued operation. For full details see Financial Review and Financial Statements.